- Home
- VSTE vs BRNS Comparison
VSTE vs BRNS Comparison
Compare VSTE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- BRNS
- Stock Information
- Founded
- VSTE 2009
- BRNS 2016
- Country
- VSTE Australia
- BRNS United Kingdom
- Employees
- VSTE N/A
- BRNS N/A
- Industry
- VSTE
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- BRNS Health Care
- Exchange
- VSTE Nasdaq
- BRNS Nasdaq
- Market Cap
- VSTE 51.9M
- BRNS 43.8M
- IPO Year
- VSTE N/A
- BRNS 2021
- Fundamental
- Price
- VSTE $0.61
- BRNS $1.00
- Analyst Decision
- VSTE
- BRNS Strong Buy
- Analyst Count
- VSTE 0
- BRNS 2
- Target Price
- VSTE N/A
- BRNS $3.00
- AVG Volume (30 Days)
- VSTE 3.1M
- BRNS 43.4K
- Earning Date
- VSTE 01-01-0001
- BRNS 03-19-2025
- Dividend Yield
- VSTE N/A
- BRNS N/A
- EPS Growth
- VSTE N/A
- BRNS N/A
- EPS
- VSTE N/A
- BRNS N/A
- Revenue
- VSTE $342,000.00
- BRNS $14,969,000.00
- Revenue This Year
- VSTE N/A
- BRNS $1,803.87
- Revenue Next Year
- VSTE N/A
- BRNS N/A
- P/E Ratio
- VSTE N/A
- BRNS N/A
- Revenue Growth
- VSTE N/A
- BRNS 106.21
- 52 Week Low
- VSTE $0.60
- BRNS $0.80
- 52 Week High
- VSTE $11.99
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- VSTE 30.08
- BRNS 46.05
- Support Level
- VSTE $0.62
- BRNS $0.96
- Resistance Level
- VSTE $0.96
- BRNS $1.15
- Average True Range (ATR)
- VSTE 0.09
- BRNS 0.12
- MACD
- VSTE -0.00
- BRNS 0.00
- Stochastic Oscillator
- VSTE 4.06
- BRNS 16.67
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.